InFLAMES Flagship
1 of 3
18 of 162
- Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors : The phase I/II first-in-human MATINS trial (2023)
- Bexmarilimab plus azacitidine for high-risk myelodysplastic syndrome and relapsed or refractory acute myeloid leukaemia: results from the dose-escalation part of a multicentre, single-arm, phase 1/2 trial (2025)
- Bias in O-Information Estimation (2024)
- Bioactive glasses promote rapid pre-osteoblastic cell migration in contrast to hydroxyapatite, while carbonated apatite shows migration inhibiting properties (2023)
- Bioaffinity Recognition of Extracellular Vesicle Glycosylations (2024)
- Biodistribution, Safety Profile, and Radiation Dosimetry of [18F]SYN2, a PET Cardiac Perfusion Tracer, in Healthy Subjects (2025)
- Bioengineering structural anisotropy in living tissues (2025)
- Biological Evaluation of Molecular Spherical Nucleic Acids: Targeting Tumors via a Hybridization-Based Folate Decoration (2025)
- Biomarkers of nanomaterials hazard from multi-layer data (2022)
- Biomarkers of viral and bacterial infection in rhinovirus pneumonia (2023)
UTU Research Portal